Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer    PFE

PFIZER (PFE)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 02/21 10:02:38 pm
35.76 USD   -0.69%
02/20PFIZER : WINDOM - Dennis R
AQ
02/20PFIZER : Merck kgaa, darmstadt, germany, and pfizer provide update o..
AQ
02/19UK shares retreat as Reckitt disappoint
RE
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies
Summary
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • The company is one of the best yield companies with high dividend expectations.
  • Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
Weaknesses
  • According to Thomson-Reuters' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • With an enterprise value anticipated at 4.38 times the sales for the current fiscal year, the company turns out to be overvalued.
Ratings chart
Sector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
PFIZER-2.84%216 135
JOHNSON & JOHNSON-7.19%357 710
NOVARTIS-3.37%226 667
ROCHE HOLDING LTD.-9.37%207 826
MERCK AND COMPANY-0.50%153 359
AMGEN3.23%132 827
BRISTOL-MYERS SQUIBB COMPAN..6.64%112 867
ABBOTT LABORATORIES2.12%104 732
BAYER-6.36%100 852
NOVO NORDISK A/S-8.76%100 588
SANOFI-11.62%100 124
GLAXOSMITHKLINE-1.67%91 862
ELI LILLY AND COMPANY-8.80%86 953
ASTRAZENECA-7.96%83 737
CELGENE CORPORATION-9.55%70 592
ALLERGAN PLC1.86%54 557
More Results
Financials ($)
Sales 2018 54 410 M
EBIT 2018 20 806 M
Net income 2018 13 101 M
Debt 2018 22 213 M
Yield 2018 3,79%
P/E ratio 2018 16,53
P/E ratio 2019 15,38
EV / Sales 2018 4,38x
EV / Sales 2019 4,24x
Capitalization 216 B
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart PFIZER
Duration : Period : Day
Pfizer Technical Analysis Chart | PFE | US7170811035 | 4-Traders
Duration : Period : Week
Pfizer Technical Analysis Chart | PFE | US7170811035 | 4-Traders